KPJ Healthcare registers best-ever annual profit


KUALA LUMPUR: KPJ Healthcare Bhd is exploring opportunities abroad after the hospital operator posted its best-ever annual results amid ongoing expansion.

On its outlook for 2020, the company said the additional capacity from new hospitals which has started its operation, coupled with the completion of the expansion at the existing hospitals will enable the group to cater rising demand for healthcare services by the local and foreign patients.

Shares in KPJ was up one sen at 93 sen at 3.30pm.

For the financial year ended Dec 31, 2019 (FY19) net profit rose 18% to RM211.4mil, or 4.95 sen a share.

Revenue climbed 7% higher to RM3.6bil.

“Year-on-year organic growth acceleration was supported by strong momentum of our Malaysian hospital operations – resulting in the stellar financial performance," KPJ’s president and managing director Datuk Amiruddin Abdul Satar said in a statement today.

He said the group will also be exploring possible expansion of new markets like Vietnam, China and the Middle East, as part of the group’s big push on medical tourism into Malaysia.

"With the added capacity of our network hospitals arising from recent greenfield and brownfield development, KPJ is bullish about its prospect of expanding its foreign patient segment." he said.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

KPJ Healthcare

   

Did you find this article insightful?

Yes
No

Next In Business News

Market cautious, eyes on Budget passage
OCK earnings remain highly sustainable on recurring income, says Kenanga
Maybank IB Research has Buy on IJM Corp, higher TP of RM1.98
Kenanga maintains 'market perform' on IOI Properties
Asian shares slip as investors pause for breath after massive rally
South Korea leaves policy rate unchanged
Trading ideas: Ekovest, GDEx, Telekom, MPI, IJM Corp
MH17 judges reject request to investigate alternative crash scenarios
Oil price rallies past 8-mth high on US crude inventory draw, vaccine hopes
Tesla's upcoming S&P 500 debut fuels 'crazy' trading volume

Stories You'll Enjoy